Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Gap Down – Should You Sell?

Posted by Brenda Bartman on Nov 9th, 2026

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) shares gapped down prior to trading on Monday. The stock had previously closed at $40.23, but opened at $38.29. Carl Zeiss Meditec shares last traded at $38.21, with a volume of 212 shares traded.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 6th. UBS Group cut Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. The Goldman Sachs Group downgraded Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research note on Monday, October 5th. Finally, Morgan Stanley assumed coverage on shares of Carl Zeiss Meditec in a report on Wednesday, September 2nd. They issued an “underweight” rating for the company. Two research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Strong Sell”.

Check Out Our Latest Stock Analysis on CZMWY

Carl Zeiss Meditec Stock Performance

The business’s fifty day moving average price is $36.64 and its 200 day moving average price is $32.88.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a medical technology company headquartered in Jena, Germany, and part of the ZEISS Group. The company develops, manufactures and distributes equipment and solutions for ophthalmology and microsurgery, serving hospitals, clinics and medical professionals worldwide.

Its ophthalmic portfolio includes diagnostic systems for examining the eye, equipment for cataract and refractive surgery, surgical lasers, intraocular lenses and other related products. The company also supplies surgical microscopes, visualization systems and digital technologies used in neurosurgery, spine surgery, ear, nose and throat procedures, and other microsurgical specialties.

Carl Zeiss Meditec was established in 2002 through the combination of the ophthalmic activities of Carl Zeiss and Asclepion-Meditec.